Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Multikine lowers cholesterol in clinical studies

Sep. 14, 2004

Advanced Viral Research plans IND filing for injectable AVR-118

Sep. 13, 2004

HGS-ETR1 advanced into phase II

Sep. 13, 2004

Takara Bio and CAMS to codevelop cancer immunotherapies in China

Sep. 9, 2004

Positive interim results from phase II trials of TroVax

Sep. 3, 2004

Antitumor efficacy of ABX-EGF in metastatic renal cancer

Sep. 1, 2004

Aphton seeks Canadian registration of Insegia in pancreatic cancer

Aug. 30, 2004

SGN-40 receives orphan drug designation for multiple myeloma

Aug. 26, 2004

Medarex reaches SPA agreement for phase III trial of MDX-010

Aug. 26, 2004

Orphan drug status for HuMax-CD4

Aug. 24, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...